21.03.2017 • NewsDede Willamspropanolconstruction

Oxea Builds new Propanol Unit in Texas

US petrochemical producer Oxea has begun construction on a new plant at Bay City, Texas, for 100,000 t/y of propanol and 40,000 t/year of propionaldehyde.

CEO Salim Al Huthaili,said the capacity addition is another example of Oxea’s...
CEO Salim Al Huthaili,said the capacity addition is another example of Oxea’s commitment as a reliable supplier. He said the company is significantly investing in its production platforms and continuously seeking opportunities for differentiation. “We aim for further expansion of our portfolio and growth in volumes over the coming period,” he added.

Purnendu Rai, executive vice president, global sales and oxo-intermediates at the Dallas, Texas-based company, said the project reflects a long-term selective growth strategy and helps to reinforce Oxea’s strong position as the largest producer of propanol worldwide.

CEO Salim Al Huthaili,said the capacity addition is another example of Oxea’s commitment as a reliable supplier. He said the company is significantly investing in its production platforms and continuously seeking opportunities for differentiation. “We aim for further expansion of our portfolio and growth in volumes over the coming period,” he added.

The construction management contract for the Propanol 2 project has been awarded to US-based Jacobs Engineering Group, which will deliver pre-construction planning and construction management services.

Company

Logo:

Oxea

Rheinpromenade 4a
40789 Monheim am Rhein
Germany

Company contact







Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read